DISEASE INDICATIONS: Sickle Cell Disease

MANUFACTURER: Novartis

USAGE: Intravenous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Adakveo is a medication used to lower the frequency of vaso-occlusive crises in sickle cell disease patients by blocking a molecule called P-selectin.